Novabay Pharmaceuticals Stock Overlap Studies Triple Exponential Moving Average

NBY Stock  USD 0.08  0  6.21%   
NovaBay Pharmaceuticals overlap studies tool provides the execution environment for running the Triple Exponential Moving Average study and other technical functions against NovaBay Pharmaceuticals. NovaBay Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triple Exponential Moving Average study function is designed to identify and follow existing trends. NovaBay Pharmaceuticals overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was twenty-one with a total number of output elements of fourty. NovaBay Pharmaceuticals Triple Exponential Moving Average indicator shows smoothing effect of NovaBay Pharmaceuticals price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

NovaBay Pharmaceuticals Technical Analysis Modules

Most technical analysis of NovaBay Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NovaBay from various momentum indicators to cycle indicators. When you analyze NovaBay charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About NovaBay Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NovaBay Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of NovaBay Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing NovaBay Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NovaBay Pharmaceuticals's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of NovaBay Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for NovaBay Pharmaceuticals, we also check how macroeconomic factors affect NovaBay Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover2.666.136.053.5
Days Of Inventory On Hand423.38189.42153.73249.02
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NovaBay Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.096.14
Details
Intrinsic
Valuation
LowRealHigh
0.091.727.77
Details
2 Analysts
Consensus
LowTargetHigh
6.056.657.38
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.25-0.15-0.05
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as NovaBay Pharmaceuticals. Your research has to be compared to or analyzed against NovaBay Pharmaceuticals' peers to derive any actionable benefits. When done correctly, NovaBay Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in NovaBay Pharmaceuticals.

Align your values with your investing style

In addition to having NovaBay Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Driverless Cars Idea
Driverless Cars
Invested a lot of shares
Manufacturing Idea
Manufacturing
Invested over 40 shares
Banking Idea
Banking
Invested over 50 shares
ESG Investing Idea
ESG Investing
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 70 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Investor Favorites Idea
Investor Favorites
Invested over 200 shares
When determining whether NovaBay Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NovaBay Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novabay Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novabay Pharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.
Note that the NovaBay Pharmaceuticals information on this page should be used as a complementary analysis to other NovaBay Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for NovaBay Stock analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Is NovaBay Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBay Pharmaceuticals. If investors know NovaBay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NovaBay Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.96)
Revenue Per Share
3.494
Quarterly Revenue Growth
0.023
Return On Assets
(0.25)
Return On Equity
(1.39)
The market value of NovaBay Pharmaceuticals is measured differently than its book value, which is the value of NovaBay that is recorded on the company's balance sheet. Investors also form their own opinion of NovaBay Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NovaBay Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NovaBay Pharmaceuticals' market value can be influenced by many factors that don't directly affect NovaBay Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NovaBay Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NovaBay Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NovaBay Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.